148 related articles for article (PubMed ID: 24410313)
1. Clofarabine in the treatment of myelodysplastic syndromes.
Bryan J; Kantarjian H; Prescott H; Jabbour E
Expert Opin Investig Drugs; 2014 Feb; 23(2):255-63. PubMed ID: 24410313
[TBL] [Abstract][Full Text] [Related]
2. Clofarabine in leukemia.
Ghanem H; Jabbour E; Faderl S; Ghandhi V; Plunkett W; Kantarjian H
Expert Rev Hematol; 2010 Feb; 3(1):15-22. PubMed ID: 21082931
[TBL] [Abstract][Full Text] [Related]
3. Clofarabine for myelodysplastic syndromes.
Tiu RV; Traina F; Sekeres MA
Expert Opin Investig Drugs; 2011 Jul; 20(7):1005-14. PubMed ID: 21591997
[TBL] [Abstract][Full Text] [Related]
4. The role of clofarabine in acute myeloid leukemia.
Ghanem H; Kantarjian H; Ohanian M; Jabbour E
Leuk Lymphoma; 2013 Apr; 54(4):688-98. PubMed ID: 22957815
[TBL] [Abstract][Full Text] [Related]
5. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
Lech-Maranda E; Korycka A; Robak T
Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of anti-cancer action and pharmacology of clofarabine.
Zhenchuk A; Lotfi K; Juliusson G; Albertioni F
Biochem Pharmacol; 2009 Dec; 78(11):1351-9. PubMed ID: 19576186
[TBL] [Abstract][Full Text] [Related]
7. Clofarabine in adult acute leukemias: clinical success and pharmacokinetics.
Cooper T; Kantarjian H; Plunkett W; Gandhi V
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1417-23. PubMed ID: 15571270
[TBL] [Abstract][Full Text] [Related]
8. Clofarabine: past, present, and future.
Kantarjian HM; Jeha S; Gandhi V; Wess M; Faderl S
Leuk Lymphoma; 2007 Oct; 48(10):1922-30. PubMed ID: 17852710
[TBL] [Abstract][Full Text] [Related]
9. Clofarabine: a new treatment option for patients with acute myeloid leukemia.
Larson ML; Venugopal P
Expert Opin Pharmacother; 2009 Jun; 10(8):1353-7. PubMed ID: 19463072
[TBL] [Abstract][Full Text] [Related]
10. Clofarabine: emerging role in leukemias.
Sampat K; Kantarjian H; Borthakur G
Expert Opin Investig Drugs; 2009 Oct; 18(10):1559-64. PubMed ID: 19715446
[TBL] [Abstract][Full Text] [Related]
11. Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes.
Roberts DA; Wadleigh M; McDonnell AM; DeAngelo DJ; Stone RM; Steensma DP
Leuk Res; 2015 Feb; 39(2):204-10. PubMed ID: 25554239
[TBL] [Abstract][Full Text] [Related]
12. Clofarabine.
Drugs R D; 2004; 5(4):213-7. PubMed ID: 15230627
[TBL] [Abstract][Full Text] [Related]
13. Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival.
Burnett AK; Russell NH; Hunter AE; Milligan D; Knapper S; Wheatley K; Yin J; McMullin MF; Ali S; Bowen D; Hills RK;
Blood; 2013 Aug; 122(8):1384-94. PubMed ID: 23838349
[TBL] [Abstract][Full Text] [Related]
14. Clofarabine in pediatric acute leukemia: current findings and issues.
Hijiya N; Barry E; Arceci RJ
Pediatr Blood Cancer; 2012 Sep; 59(3):417-22. PubMed ID: 22354543
[TBL] [Abstract][Full Text] [Related]
15. Novel purine nucleoside analogues for hematological malignancies.
Korycka A; Lech-Marańda E; Robak T
Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):123-36. PubMed ID: 18537755
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs.
Bagley RG; Roth S; Kurtzberg LS; Rouleau C; Yao M; Crawford J; Krumbholz R; Lovett D; Schmid S; Teicher BA
Int J Oncol; 2009 May; 34(5):1329-40. PubMed ID: 19360345
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of clofarabine in adult patients with acute myeloid leukemia in Japan.
Suzuki T; Yamauchi T; Ando K; Nagai T; Kakihana K; Miyata Y; Uchida T; Tabata Y; Ogura M
Jpn J Clin Oncol; 2013 Dec; 43(12):1177-83. PubMed ID: 24130086
[TBL] [Abstract][Full Text] [Related]
18. G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm.
Becker PS; Medeiros BC; Stein AS; Othus M; Appelbaum FR; Forman SJ; Scott BL; Hendrie PC; Gardner KM; Pagel JM; Walter RB; Parks C; Wood BL; Abkowitz JL; Estey EH
Am J Hematol; 2015 Apr; 90(4):295-300. PubMed ID: 25545153
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.
Alatrash G; Thall PF; Valdez BC; Fox PS; Ning J; Garber HR; Janbey S; Worth LL; Popat U; Hosing C; Alousi AM; Kebriaei P; Shpall EJ; Jones RB; de Lima M; Rondon G; Chen J; Champlin RE; Andersson BS
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1792-1800. PubMed ID: 27377901
[TBL] [Abstract][Full Text] [Related]
20. Phase I Study of Clofarabine and 2-Gy Total Body Irradiation as a Nonmyeloablative Preparative Regimen for Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia Consortium Study.
Soni S; Abdel-Azim H; McManus M; Nemecek E; Sposto R; Woolfrey A; Frangoul H
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1134-1141. PubMed ID: 28396162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]